These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9492982)

  • 1. Therapeutic potential of anti-IgE antibodies.
    Heusser C; Jardieu P
    Curr Opin Immunol; 1997 Dec; 9(6):805-13. PubMed ID: 9492982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-IgE--a new treatment for allergic diseases].
    Berkun Y; Shalit M
    Harefuah; 2002 Mar; 141(3):260-2, 314. PubMed ID: 11944220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of anti-IgE antibodies in vivo.
    Stadler BM; Nakajima K; Yang XD; de Weck AL
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):206-8. PubMed ID: 2468615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of the therapeutic potential of non-anaphylactogenic anti-IgE antibodies in murine models of skin reaction, lung function and inflammation.
    Heusser CH; Wagner K; Bews JP; Coyle A; Bertrand C; Einsle K; Kips J; Eum SY; Lefort J; Vargaftig BB
    Int Arch Allergy Immunol; 1997; 113(1-3):231-5. PubMed ID: 9130531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein.
    Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M
    Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-IgE and future treatments for respiratory allergies].
    Tunon-De-Lara JM; Raherison C; Berger P
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 1):114-20. PubMed ID: 12843997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a peptide conjugate vaccine for inducing therapeutic anti-IgE antibodies.
    Licari A; Castagnoli R; De Sando E; Marseglia GL
    Expert Opin Biol Ther; 2017 Apr; 17(4):429-434. PubMed ID: 28132528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-anti-IgE idiotypic antibodies mimic IgE in their binding to the Fc epsilon receptor.
    Baniyash M; Eshhar Z
    Eur J Immunol; 1987 Sep; 17(9):1337-42. PubMed ID: 2443366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human IgE monoclonal antibodies recognizing epitopes related to the binding sites of high and low affinity IgE receptors.
    Takemoto H; Nishimura S; Kosada Y; Hata S; Takagi S; Hosoi S; Ezumi K; Ide M; Harada S
    Microbiol Immunol; 1994; 38(1):63-71. PubMed ID: 7519718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody.
    Coyle AJ; Wagner K; Bertrand C; Tsuyuki S; Bews J; Heusser C
    J Exp Med; 1996 Apr; 183(4):1303-10. PubMed ID: 8666888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of allergy.
    Miescher SM; Vogel M
    Mol Aspects Med; 2002 Dec; 23(6):413-62. PubMed ID: 12385747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases.
    Chang TW; Davis FM; Sun NC; Sun CR; MacGlashan DW; Hamilton RG
    Biotechnology (N Y); 1990 Feb; 8(2):122-6. PubMed ID: 1369991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
    D'Amato G; Oldani V; Donner CF
    Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgE therapy.
    Jardieu P
    Curr Opin Immunol; 1995 Dec; 7(6):779-82. PubMed ID: 8679119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
    Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
    Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimotope and anti-idiotypic vaccines to induce an anti-IgE response.
    Stadler BM; Zürcher AW; Miescher S; Kricek F; Vogel M
    Int Arch Allergy Immunol; 1999; 118(2-4):119-21. PubMed ID: 10224356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).
    Chrétien I; Helm BA; Marsh PJ; Padlan EA; Wijdenes J; Banchereau J
    J Immunol; 1988 Nov; 141(9):3128-34. PubMed ID: 2459242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular targets of anti-IgE antibodies.
    Inführ D; Crameri R; Lamers R; Achatz G
    Allergy; 2005 Aug; 60(8):977-85. PubMed ID: 15969677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.